As our understanding of post-traumatic stress disorder (PTSD) improves, so
too should our psychopharmacological approaches to treating this common and
sometimes disabling condition. Treatment with drugs can lead to improvemen
t in PTSD. The most effective drugs seem to be those that have their action
on the serotonergic system, such as the selective serotonin reuptake inhib
itors and the monoamine oxidase inhibitors. Higher dosages and longer perio
ds of treatment seem to be required in many cases for adequate therapeutic
response. Here we examine the main groups of agents used in the pharmacolog
ical treatment of this disorder. With a background of relatively few random
ized therapeutic trials and others beset by limitations, it remains difficu
lt currently to draw confident conclusions in the approach to drug manageme
nt.